CFO Mark Livingston Sells 158 Shares at $26.20 in Routine, Rule‑Compliant Move for Progyny Inc.

Insider Activity at Progyny: A Closer Look at the CFO’s Recent Sale

Progyny’s most recent insider filing on June 2, 2026 shows Chief Financial Officer Mark S. Livingston selling 158 shares at $26.20 per share, a transaction executed under a Rule 10b‑5(1) trading plan. The sale is modest—less than 0.02 % of the outstanding float—but it is part of a pattern of regular share disposals that has been building over the past few months. The CFO’s last four trades, all “sell” orders, total over 11,000 shares and have occurred at prices ranging from $17.50 to $26.20, indicating a gradual, systematic reduction of his stake.

What Does This Mean for Investors?

For investors, the CFO’s incremental sales are not an alarming signal. The timing aligns with the vesting schedule of his restricted‑stock units, and the amounts are consistent with his previously filed 10b‑5(1) plan. The broader market has been modestly bearish, with Progyny’s shares slipping 1.92 % in the week and 32 % in the month, but the company’s fundamentals remain solid—its revenue pipeline is expanding, and its price‑to‑earnings ratio of 34.45 suggests that investors are pricing in strong growth. The CFO’s trades are likely driven by personal liquidity needs rather than a lack of confidence in the company’s trajectory.

CFO Mark S. Livingston: A Transaction Profile

Livingston’s insider history paints the picture of a disciplined, rule‑compliant officer. Since March 2026, he has executed 11 sales totaling 23,000 shares, interspersed with a few large purchases in early March when he exercised a sizable stock‑option package of 66,289 shares. His average sale price has risen from the low‑$17 range in March to over $25 in May, matching the company’s upward price trend. Unlike some insiders who buy aggressively to signal conviction, Livingston’s pattern is more conservative, focusing on gradual divestiture and periodic re‑investment when his options mature.

How It Fits Into Company‑Wide Insider Trends

The CFO’s activity is mirrored by other key executives. Scott Cheryl and Geoffrey Clapp each executed four trades in early June, a mix of buys and sells that suggest they are balancing their portfolios rather than making strategic bets on the stock. The overall insider flow in June has been neutral: the net shares held by executives have barely changed, and the market cap of $2.05 billion remains stable. This equilibrium is reassuring for shareholders, indicating that the management team is not over‑exposing itself to short‑term market swings.

Takeaway for the Market

In a sector where employee benefits companies can face regulatory uncertainty, Progyny’s steady insider activity signals confidence in its business model. While the CFO’s sale is a routine move, it reflects a broader trend of careful portfolio management among the company’s senior leaders. Investors can view these transactions as a normal part of corporate governance rather than a warning sign. The company’s earnings outlook, coupled with a healthy cash position and an expanding client base, keeps the narrative focused on long‑term value creation rather than short‑term share price volatility.